1-(2-(4-Iodophenoxy)ethyl)pyrrolidine → 3-(4-Chloro-phenyl)-6-[4-(2-pyrrolidin-1-yl-ethoxy)-phenylethynyl]-pyridazine

HRID 271705노트

반응식

HRID 271705 반응식
I[C:2]1[CH:15]=[CH:14][C:5]([O:6][CH2:7][CH2:8][N:9]2[CH2:13][CH2:12][CH2:11][CH2:10]2)=[CH:4][CH:3]=1.[Cl:16][C:17]1[CH:22]=[CH:21][C:20]([C:23]2[N:24]=[N:25][C:26]([C:29]#[CH:30])=[CH:27][CH:28]=2)=[CH:19][CH:18]=1>>[Cl:16][C:17]1[CH:18]=[CH:19][C:20]([C:23]2[N:24]=[N:25][C:26]([C:29]#[C:30][C:2]3[CH:15]=[CH:14][C:5]([O:6][CH2:7][CH2:8][N:9]4[CH2:13][CH2:12][CH2:11][CH2:10]4)=[CH:4][CH:3]=3)=[CH:27][CH:28]=2)=[CH:21][CH:22]=1

참가 물질

3

실험 절차

Prepared according to general working method I from 1-[2-(4-iodo-phenoxy)-ethyl]-pyrrolidine (200 mg, 0.63 mmol) and 3-(4-chloro-phenyl)-6-ethynyl-pyridazine (135 mg, 0.63 mmol).

후처리

  1. customPrepared

출처 및 근거

ORD 기록
ord-578860f364ca47dbb073080e2c29f1b9
출처 데이터셋
uspto-grants-2008_11
특허 번호
US07452911B2

반응 노트

불러오는 중…